DE68926569T2 - Cho-zellen befähigt enzymatisch aktive rekombinante-glukocerebrosidase zu produzieren - Google Patents
Cho-zellen befähigt enzymatisch aktive rekombinante-glukocerebrosidase zu produzierenInfo
- Publication number
- DE68926569T2 DE68926569T2 DE68926569T DE68926569T DE68926569T2 DE 68926569 T2 DE68926569 T2 DE 68926569T2 DE 68926569 T DE68926569 T DE 68926569T DE 68926569 T DE68926569 T DE 68926569T DE 68926569 T2 DE68926569 T2 DE 68926569T2
- Authority
- DE
- Germany
- Prior art keywords
- glucocerebrosidase
- cell
- encymative
- production
- cho cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00802—Methods or devices for eye surgery using laser for photoablation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B2018/206—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the laser light passing along a liquid-filled conduit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/0087—Lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
- A61F2009/00887—Cataract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28958988A | 1988-12-23 | 1988-12-23 | |
PCT/US1989/005801 WO1990007573A1 (en) | 1988-12-23 | 1989-12-22 | Enzymatically active recombinant glucocerebrosidase |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68926569D1 DE68926569D1 (de) | 1996-07-04 |
DE68926569T2 true DE68926569T2 (de) | 1996-09-26 |
Family
ID=23112189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68926569T Expired - Lifetime DE68926569T2 (de) | 1988-12-23 | 1989-12-22 | Cho-zellen befähigt enzymatisch aktive rekombinante-glukocerebrosidase zu produzieren |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0401362B1 (de) |
JP (1) | JP2893481B2 (de) |
AT (1) | ATE138686T1 (de) |
DE (1) | DE68926569T2 (de) |
ES (1) | ES2093642T3 (de) |
WO (1) | WO1990007573A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970005049B1 (ko) * | 1990-07-16 | 1997-04-11 | 더 리젠츠 오브 더 유니벌시티 오브 캘리포니아 | 바쿨로비루스 발현 시스템, 이 벡터 시스템을 포함하는 이종성 무척추동물 숙주세포, 상기 시스템에 의해 생산되는 가용성의 정제된 야생형 망막아세포종 폴리펩티드 및 이 폴리펩티드의 생산 방법 |
US5382524A (en) * | 1990-10-24 | 1995-01-17 | The Mount Sinai School Of Medicine Of The City University Of New York | Cloning and expression of biologically active α-n-acetylgalactosaminidase |
CA2099876C (en) * | 1991-01-21 | 2002-03-26 | Michael L. Hayes | Production of enzymatically active glucocerebrosidase from recombinant cells |
WO1993013196A2 (en) * | 1991-12-24 | 1993-07-08 | Genzyme Corporation | Method for increasing recombinant protein production |
DK0675727T3 (da) * | 1992-12-10 | 2002-08-05 | Enzon Inc | Glycolipidenzympolymerkonjugater |
AU6809494A (en) * | 1992-12-21 | 1994-07-19 | Enzon, Inc. | Purification of proteinaceous material |
WO1996004001A1 (en) * | 1994-08-05 | 1996-02-15 | Molecular/Structural Biotechnologies, Inc. | Site-specific biomolecular complexes |
AU764686B2 (en) | 1998-08-28 | 2003-08-28 | Duke University | Adenoviruses deleted in the IVa2, 100K, polymerase and/or preterminal protein sequences |
WO2000063351A2 (en) * | 1999-04-21 | 2000-10-26 | Incyte Genomics, Inc. | Carbohydrate-modifying enzymes |
EP1246915A2 (de) * | 1999-12-30 | 2002-10-09 | Maxygen Aps | Verbesserte lysosomale enzyme und lysosomale enzymaktivatoren |
WO2001077307A2 (en) * | 2000-04-06 | 2001-10-18 | Exegenics, Inc. | Expression system for efficiently producing clinically effective lysosomal enzymes (glucocerebrosidase) |
WO2002002597A2 (en) * | 2000-06-30 | 2002-01-10 | Maxygen Aps | Peptide extended glycosylated polypeptides |
US7138262B1 (en) | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
EP1986612B1 (de) | 2006-02-07 | 2012-09-12 | Shire Human Genetic Therapies, Inc. | Stabilisierte Zubereitung enthaltend Glucocerebrosidase |
WO2011017177A1 (en) | 2009-07-28 | 2011-02-10 | Shire Human Genetic Therapies | Compositions and methods for treating gaucher disease |
EP2595651B1 (de) | 2010-07-19 | 2017-03-29 | Shire Human Genetic Therapies, Inc. | Kodonoptimierte zelllinie für den mannoserezeptor-c vom typ 1 (mrc1) und anwendungen davon |
EP3144386B1 (de) | 2010-11-08 | 2019-05-29 | Amicus Therapeutics, Inc. | Variante und rekombinante beta-glucocerebrosidase-proteine mit erhöhter stabilität und erhöhter zurückgehaltener katalytischer aktivität |
KR102096752B1 (ko) | 2012-03-02 | 2020-04-02 | 샤이어 휴먼 지네틱 테라피즈 인크. | Iii형 고셔병을 치료하기 위한 조성물 및 방법 |
RU2676956C1 (ru) * | 2017-08-25 | 2019-01-11 | Общество с ограниченной ответственностью "Международный Биотехнологический Центр "Генериум" | Антитела для связывания имиглюцеразы и их применение в аффинной хроматографии |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
EP0393143A4 (en) * | 1987-12-23 | 1991-09-11 | Us Commerce | Cloned dna for synthesizing unique glucocerebrosidase |
-
1989
- 1989-12-22 ES ES90901476T patent/ES2093642T3/es not_active Expired - Lifetime
- 1989-12-22 WO PCT/US1989/005801 patent/WO1990007573A1/en active IP Right Grant
- 1989-12-22 EP EP90901476A patent/EP0401362B1/de not_active Expired - Lifetime
- 1989-12-22 DE DE68926569T patent/DE68926569T2/de not_active Expired - Lifetime
- 1989-12-22 JP JP2502257A patent/JP2893481B2/ja not_active Expired - Lifetime
- 1989-12-22 AT AT90901476T patent/ATE138686T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE68926569D1 (de) | 1996-07-04 |
ES2093642T3 (es) | 1997-01-01 |
EP0401362A4 (en) | 1991-09-11 |
ATE138686T1 (de) | 1996-06-15 |
JP2893481B2 (ja) | 1999-05-24 |
EP0401362B1 (de) | 1996-05-29 |
JPH03502289A (ja) | 1991-05-30 |
WO1990007573A1 (en) | 1990-07-12 |
EP0401362A1 (de) | 1990-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68926569D1 (de) | Cho-zellen befähigt enzymatisch aktive rekombinante-glukocerebrosidase zu produzieren | |
NO861905L (no) | Fremgangsmaate for fremstilling av maursyre. | |
HUT43636A (en) | Process for producing 2-keto-l-gulonic acid | |
ES8507179A1 (es) | Un metodo de conseguir una deseada proteina madura en una celula hospedante de vertebrado. | |
IT7920255A0 (it) | Procedimento per produrre idrogeno e ossigeno, nonche' cella elettrolitica per attuare tale procedimento. | |
EP0145390A3 (de) | Methode zur Herstellung von nicht-glykosyliertem humanen Interleukin-2 Protein | |
JPS5794298A (en) | Production of isomaltulose by using fixed microorganism | |
EP1099758A3 (de) | Verfahren und Gastzellen zur Herstellung von Zweikettigen Relaxin-Polypeptide | |
DE68915692D1 (de) | Fermentationsverfahren zur Herstellung von 2-Keto-L-Gulonsäure. | |
DK617386A (da) | Fremgangsmaade til fremstilling af 2-keto-d-glucarsyre | |
DK157886C (da) | Xyloseisomerase og fremgangsmaade til fremstilling deraf | |
DE3164541D1 (en) | Production of ethanol by yeast using xylulose | |
ATE239736T1 (de) | Herstellung von clavunalat-salzen | |
DE3262622D1 (en) | Preparation of a glutaraldehyde precursor | |
DK227184A (da) | Agarfibre indeholdende deri immobiliserede enzymholdige mikroorganismeceller og fremgangsmaade til fremstilling deraf | |
IL89242A (en) | Process for producing a recombinant microorganism capable of converting glucose into 2-keto-l-gulonic acid,the microorganism obtained by said process and its use in converting glucose into 2-keto-l-gulonic acid | |
ATE21117T1 (de) | Gaerungsverfahren zur herstellung von alphaisopropylapfels|ure. | |
IT7925016A0 (it) | Procedimento per produrre idrogeno e acido solforico per decomposizione elettrochimica di un elettrolito, nonche' elettrodo per attuare la decomposizione elettrochimica. | |
ATE94906T1 (de) | Verfahren zur herstellung von l-alphaaminos|uren. | |
CO5241325A1 (es) | Procedimiento de cultivo masivo de celulas de mamifero para la obtencion de eritropoyetina humana recombinante y la eritropoyetina humana recombinante obtenida con tal procedimiento | |
CA2006709A1 (en) | Enzymatically active recombinant glucocerebrosidase | |
SE9303273D0 (sv) | Process for production of acidified process streams | |
ATE32718T1 (de) | Verfahren zur herstellung von (s)glyceraldehydacetonid. | |
IT8521530A0 (it) | Processo per produrre acido cinnamico. | |
ES476659A1 (es) | Procedimiento de preparacion de amino-2-etil-2-tiofeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |